- Home
- RNXT vs NTWK Comparison
RNXT vs NTWK Comparison
Compare RNXT & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- NTWK
- Stock Information
- Founded
- RNXT 2012
- NTWK 1997
- Country
- RNXT United States
- NTWK United States
- Employees
- RNXT N/A
- NTWK N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- NTWK Computer Software: Prepackaged Software
- Sector
- RNXT Health Care
- NTWK Technology
- Exchange
- RNXT Nasdaq
- NTWK Nasdaq
- Market Cap
- RNXT 34.0M
- NTWK N/A
- IPO Year
- RNXT 2021
- NTWK 1998
- Fundamental
- Price
- RNXT $1.02
- NTWK $2.35
- Analyst Decision
- RNXT Strong Buy
- NTWK
- Analyst Count
- RNXT 1
- NTWK 0
- Target Price
- RNXT $9.00
- NTWK N/A
- AVG Volume (30 Days)
- RNXT 134.5K
- NTWK 27.2K
- Earning Date
- RNXT 05-09-2025
- NTWK 05-08-2025
- Dividend Yield
- RNXT N/A
- NTWK N/A
- EPS Growth
- RNXT N/A
- NTWK N/A
- EPS
- RNXT N/A
- NTWK N/A
- Revenue
- RNXT N/A
- NTWK $62,048,128.00
- Revenue This Year
- RNXT N/A
- NTWK N/A
- Revenue Next Year
- RNXT N/A
- NTWK N/A
- P/E Ratio
- RNXT N/A
- NTWK N/A
- Revenue Growth
- RNXT N/A
- NTWK 9.28
- 52 Week Low
- RNXT $0.77
- NTWK $2.28
- 52 Week High
- RNXT $1.69
- NTWK $3.34
- Technical
- Relative Strength Index (RSI)
- RNXT 46.22
- NTWK 33.97
- Support Level
- RNXT $0.91
- NTWK $2.33
- Resistance Level
- RNXT $1.03
- NTWK $2.54
- Average True Range (ATR)
- RNXT 0.07
- NTWK 0.11
- MACD
- RNXT 0.01
- NTWK -0.01
- Stochastic Oscillator
- RNXT 77.78
- NTWK 9.09
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.